NAMMI THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Sept 2022)
What this means for you
This application is over — abandoned 26 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88317197
- Mark type
- Stylized text
- Filed
- 26 Feb 2019
- Published for opposition
- 25 Jun 2019
- Abandoned
- 26 Sept 2022
- Attorney of record
- Britt L. Anderson
Goods and services
- Class 042 — Scientific and technological services: Clinical research in the field of immunotherapy; research and development services in the field of treatment of cancer and tumors; research and development in the field of development of pharmaceutical products
Owner
- NAMMI THERAPEUTICS, INC.,, LOS ANGELES, CA, US
- NAMMI OPS, INC., LOS ANGELES, CA, US
- Nammi Therapeutics, Inc., Los Angeles, CA, US
- Nammi Therapeutics, Inc., Los Angeles, CA, US
Prosecution history
- 26 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2022 — SOU EXTENSION 5 GRANTED
- 18 Feb 2022 — SOU EXTENSION 5 FILED
- 24 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2021 — SOU EXTENSION 4 GRANTED
- 17 Aug 2021 — SOU EXTENSION 4 FILED
- 17 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 31 Mar 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Mar 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2021 — SOU EXTENSION 3 GRANTED